Officials with the Utah Department of Health are recommending providers temporarily pause administrating the Johnson & Johnson COVID-19 vaccine after the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination.